Difference between revisions of "Part:BBa K1189031:Experience"

 
Line 1: Line 1:
 
 
__NOTOC__
 
__NOTOC__
 
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
 
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
Line 5: Line 4:
  
 
===Applications of BBa_K1189031===
 
===Applications of BBa_K1189031===
 
+
<html>
 +
<figure>
 +
<img src="https://static.igem.org/mediawiki/2013/thumb/0/03/YYC2013_Blac_Amp_Survival_Assay_with_colonies.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_colonies.jpg">
 +
<figcaption>
 +
<p><b>Figure 1. </b>Absorbance values at 600nm for each tube at four different time points: 0, 30, 60 and 120min. The cultures that expressed beta-lactamase (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189007">
 +
<span class="Green"><b>
 +
BBa_K1189007
 +
</b></span>
 +
</a>) showed higher absorbance levels, showing that the cells were able to grow in the presence of ampicillin.</a>
 +
</figcaption>
 +
<p>In addition to that, we have purified our beta-lactamase (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189007">
 +
<span class="Green"><b>
 +
BBa_K1189007
 +
</b></span>
 +
</a>) and our mobile TALE A linked to beta-lactamase construct (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >) (Figure 2) and we have demonstrated that beta-lactamase retained its enzymatic activity for both proteins. We repeated a variation of ampicillin survival assay where we pretreated LB containing ampicillin and chloramphenicol with our purified TALE A linked to beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >). We then cultured bacteria in the treated LB that only carry resistance to chloramphenicol. Therefore, the bacteria are only able to survive if the our isolated protein retained its enzymatic abilities. We can show that the bacteria susceptible to ampicillin was able to grow in the presence of our purified construct protein (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >), which means that we are expressing and purifying functional protein which is degrading the ampicillin (Figures 1 and 3). Figure 3 shows the OD at 24 hour time point from culturing where Figure 1 shows OD change over time. Both graphs show an increase in OD for cultures pre-treated with our protein demonstrating our protein is functional.</p>
 +
<figure>
 +
<img src="https://static.igem.org/mediawiki/parts/5/55/YYC2013_TALE_Blac_Western_Blot_White_Background.jpg">
 +
<figcaption>
 +
<p><b>Figure 2. </b>On the left crude lysate of beta-lactamase + His (<a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189007">
 +
<span class="Green"><b>
 +
BBa_K1189007
 +
</b></span>
 +
</a>) from different lysis protocols:  a <a href="http://2013.igem.org/Team:Calgary/Notebook/Protocols/GlassBeadsCellLysisProtocolforProteinSamples">
 +
<span class="Green"><b>
 +
mechanical
 +
</b></span>
 +
</a> and with <a href="http://2013.igem.org/Team:Calgary/Notebook/Protocols/OsmoticShock">
 +
<span class="Green"><b>
 +
sucrose
 +
</b></span>
 +
</a>, respectively. On the right, western blot of <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K782004">
 +
<span class="Green"><b>
 +
TALE A
 +
</b></span>
 +
</a>-linker-beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a>) showing that we were able to express and purify our construct.
 +
</figcaption>
 +
<figure>
 +
<img src="https://static.igem.org/mediawiki/2013/thumb/3/38/YYC2013_Blac_Amp_Survival_Assay_with_protein_24h.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_protein_24h.jpg">
 +
<figcaption>
 +
<p><b>Figure 3. </b>Absorbance values at 600nm after 24h. Amounts from 0.1µg to 20µg of TALE A-link-Beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >) were sufficient to degrade the ampicillin in the media allowing bacteria susceptible to ampicillin to grow.</a>
 +
</figcaption>
 +
<figure>
 +
<img src="https://static.igem.org/mediawiki/2013/thumb/d/de/YYC2013_Blac_Amp_Survival_Assay_with_protein_3_time_points.jpg/800px-YYC2013_Blac_Amp_Survival_Assay_with_protein_3_time_points.jpg">
 +
<figcaption>
 +
<p><b>Figure 4. </b>Absorbance values at 600nm in different time points. Amounts from 1.0µg to 10µg of TALE A-link-Beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >) were sufficient to degrade the ampicillin in the media allowing bacteria susceptible to ampicillin to grow.</a>
 +
</figcaption>
 +
        <p>After verifying that <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K782004">
 +
<span class="Green"><b>
 +
TALE A
 +
</b></span>
 +
</a>-linker-beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >) retained enzymatic activity and was able to degrade ampicillin, we performed a <a href="http://2013.igem.org/Team:Calgary/Notebook/Protocols/BenzylpenicillianAssay">
 +
<span class="Green"><b>
 +
colourimetric assay
 +
</b></span>
 +
</a> using benzylpenicillin as our substrate. We were able to see a colour change from red to yellow. This is because there is phenol red, a pH indicator, added to the substrate solution. Beta-lactamase hydrolyzes benzylpenicillin to penicillinoic acid, which changes the pH of the solution from alkaline to acidic. This pH change causes the phenol red to change from red to yellow. Our negative controls, to which benzylpenicillin was not added, remained red. We can also see the colour change correlate to the amount of purified TALE A linked to beta-lactamase present in each sample (Figure 5).</p>
 +
<figure>
 +
<img src="https://static.igem.org/mediawiki/parts/5/5b/YYC2013_Blac_PenG_Assay.jpg">
 +
<figcaption>
 +
<p><b>Figure 5. </b>Benzylpenicillin assay. On the top, the wells only had <a href="https://parts.igem.org/wiki/index.php?title=Part:BBa_K782004">
 +
<span class="Green"><b>
 +
TALE A
 +
</b></span>
 +
</a>-linker-beta-lactamase (<a href=" https://parts.igem.org/wiki/index.php?title=Part:BBa_K1189031">
 +
<span class="Green"><b>
 +
BBa_K1189031
 +
</b></span>
 +
</a >). Benzylpenicillin was added and after a 10-minute incubation at room temperature, we were able to observe a colour output from red to yellow (bottom row) while the control wells remained red.</a>
 +
</figcaption>
 +
</html>
 
===User Reviews===
 
===User Reviews===
 
<!-- DON'T DELETE --><partinfo>BBa_K1189031 StartReviews</partinfo>
 
<!-- DON'T DELETE --><partinfo>BBa_K1189031 StartReviews</partinfo>

Revision as of 06:25, 28 September 2013

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K1189031

Figure 1. Absorbance values at 600nm for each tube at four different time points: 0, 30, 60 and 120min. The cultures that expressed beta-lactamase ( BBa_K1189007 ) showed higher absorbance levels, showing that the cells were able to grow in the presence of ampicillin.

In addition to that, we have purified our beta-lactamase ( BBa_K1189007 ) and our mobile TALE A linked to beta-lactamase construct ( BBa_K1189031 ) (Figure 2) and we have demonstrated that beta-lactamase retained its enzymatic activity for both proteins. We repeated a variation of ampicillin survival assay where we pretreated LB containing ampicillin and chloramphenicol with our purified TALE A linked to beta-lactamase ( BBa_K1189031 ). We then cultured bacteria in the treated LB that only carry resistance to chloramphenicol. Therefore, the bacteria are only able to survive if the our isolated protein retained its enzymatic abilities. We can show that the bacteria susceptible to ampicillin was able to grow in the presence of our purified construct protein ( BBa_K1189031 ), which means that we are expressing and purifying functional protein which is degrading the ampicillin (Figures 1 and 3). Figure 3 shows the OD at 24 hour time point from culturing where Figure 1 shows OD change over time. Both graphs show an increase in OD for cultures pre-treated with our protein demonstrating our protein is functional.

Figure 2. On the left crude lysate of beta-lactamase + His ( BBa_K1189007 ) from different lysis protocols: a mechanical and with sucrose , respectively. On the right, western blot of TALE A -linker-beta-lactamase ( BBa_K1189031 ) showing that we were able to express and purify our construct.

Figure 3. Absorbance values at 600nm after 24h. Amounts from 0.1µg to 20µg of TALE A-link-Beta-lactamase ( BBa_K1189031 ) were sufficient to degrade the ampicillin in the media allowing bacteria susceptible to ampicillin to grow.

Figure 4. Absorbance values at 600nm in different time points. Amounts from 1.0µg to 10µg of TALE A-link-Beta-lactamase ( BBa_K1189031 ) were sufficient to degrade the ampicillin in the media allowing bacteria susceptible to ampicillin to grow.

After verifying that TALE A -linker-beta-lactamase ( BBa_K1189031 ) retained enzymatic activity and was able to degrade ampicillin, we performed a colourimetric assay using benzylpenicillin as our substrate. We were able to see a colour change from red to yellow. This is because there is phenol red, a pH indicator, added to the substrate solution. Beta-lactamase hydrolyzes benzylpenicillin to penicillinoic acid, which changes the pH of the solution from alkaline to acidic. This pH change causes the phenol red to change from red to yellow. Our negative controls, to which benzylpenicillin was not added, remained red. We can also see the colour change correlate to the amount of purified TALE A linked to beta-lactamase present in each sample (Figure 5).

Figure 5. Benzylpenicillin assay. On the top, the wells only had TALE A -linker-beta-lactamase ( BBa_K1189031 ). Benzylpenicillin was added and after a 10-minute incubation at room temperature, we were able to observe a colour output from red to yellow (bottom row) while the control wells remained red.

User Reviews

UNIQ2d76b173807f04f4-partinfo-00000001-QINU UNIQ2d76b173807f04f4-partinfo-00000002-QINU